Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Mycosis Fungoides 2Melanoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Waldenstrom Macroglobulinemia 1Neoplasms 1Neoplasm Metastasis 1Mycoses 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma 1

Interventions

fludarabine phosphate 6Peripheral Blood Stem Cell Transplantation 5Rituximab 4Mycophenolic Acid 4Cyclosporine 4Cyclophosphamide 4romidepsin 3Whole-Body Irradiation 3Methotrexate 3Everolimus 3Busulfan 3durvalumab 2Vorinostat 2Vincristine 2Tacrolimus 2Photopheresis 2Immunoglobulin G 2Filgrastim 2Etoposide 2Disulfides 2Brentuximab Vedotin 2Bortezomib 2veliparib 1tremelimumab 1tazarotenic acid 1tazarotene 1poly ICLC 1pembrolizumab 1navitoclax 1mogamulizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Lymphoma, T-Cell, Cutaneous × ProMune × Clear all
NCT00043420 2009-02-12

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Pfizer

Phase 1/2 Completed
42 enrolled
DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡